Catechol Thioethers in Parkinson’s Disease
Overview
The goal of the clinical trial aim in this project is to test whether catechol thioethers can be used as biomarkers of dopaminergic neurodegeneration.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Other
Participating in This Clinical Trial
First diagnosis of Parkinson's disease.
Gender Eligibility: All
Minimum Age: 0 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- National Institute of Environmental Health Sciences (NIEHS)
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.